Neuroleptic malignant syndrome in a patient on long-term olanzapine treatment at a stable dose: Successful treatment with dantrolene

Antonios KouparanisFirst Propedeutic Department of Internal Medicine and

Andreas BozikasFirst Propedeutic Department of Internal Medicine and

Martha SpiliotiFirst Department of Neurology, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece

Konstantinos TziomalosFirst Propedeutic Department of Internal Medicine and Correspondence[email protected]

References

Perry PJ, Wilborn CA. Serotonin syndrome vs neuroleptic malignant syndrome: A contrast of causes, diagnoses, and management. Annals of Clinical Psychiatry 2012;24:155–162
PubMed Web of Science ®Google Scholar
Shalev A, Hermesh H, Munitz H. Mortality from neuroleptic malignant syndrome. Journal of Clinical Psychiatry 1989;50:18–25
PubMed Web of Science ®Google Scholar
Szota A, Ogłodek E, Araszkiewicz A. Fever development in neuroleptic malignant syndrome during treatment with olanzapine and clozapine. Pharmacology Reports 2013;65:279–287
Google Scholar
Trollor JN, Chen X, Sachdev PS. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs 2009;23:477–492
PubMed Web of Science ®Google Scholar
Sakkas P, Davis JM, Janicak PG, Wang ZY. Drug treatment of the neuroleptic malignant syndrome. Psychopharmacology Bulletin 1991;27:381–384
PubMedGoogle Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Neuroleptic malignant syndrome in a patient on long-term olanzapine treatment at a stable dose: Successful treatment with dantrolene

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Neuroleptic malignant syndrome in a patient on long-term olanzapine treatment at a stable dose: Successful treatment with dantrolene

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date